Clinical Trial Update: An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of the OROS hydromorphone hydrochloride delivery system for cancer-related pain has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• OROS Hydromorphone HCl (Hydromorphone hydrochloride)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2013-11-25